COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry.
Scott D NewsomeAnne H CrossRobert J FoxJune HalperPamela KanellisBruce BeboDavid LiGary R CutterKottil W RammohanSalter AmberPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
Among the reported patients with NMOSD, a high mortality rate was observed, and the presence of comorbid conditions was associated with worse COVID-19 outcome. There were no deaths reported in the patients with MOGAD, although these observations are limited due to small sample size.